
Beyond Blood Clots: mRNA Technology, PAD4, and 'Calamari' Thrombosis
Molecular analysis of unusual 'calamari clots' reveals connections between lipid nanoparticles, PAD4 citrullination, and treatment-resistant thrombosis. Limited human evidence; proteomic data from investigator reports requires validation.

